NCT05445453

Brief Summary

In recent years, museums have participated in the patient care journey by using art to enhance their quality of life and well-being. Since 2015, the Montreal Museum of Fine Arts (MMFA) and Dr. Beauchet have developed an Action-Research program exploring the effects of participatory art activities for community elders conducted at the MMFA, known as the Arts \& Longevity Lab (ALL). The mandate of ALL is to improve the well-being, quality of life and health (i.e. mental and physical state) of individuals and patients through the practice of visual arts activities (i.e. arts that produce objects perceived by the eyes). Since 2019, the MMFA has developed in collaboration with Médecins Francophones du Canada museum visits prescribed by a primary care physician as a new intervention. Today, it is necessary to improve the knowledge on the effects of this museum visit prescription The overall objective of this study is to examine the effects of a visit to the MMFA prescribed by a primary care physician on the mental health (well-being and quality of life) of patients living in Montreal.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
86

participants targeted

Target at P50-P75 for not_applicable quality-of-life

Timeline
Completed

Started Jun 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 27, 2022

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

June 30, 2022

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 6, 2022

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 21, 2023

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 22, 2023

Completed
Last Updated

February 23, 2024

Status Verified

February 1, 2024

Enrollment Period

1.1 years

First QC Date

June 30, 2022

Last Update Submit

February 22, 2024

Conditions

Keywords

ArtsWell-beingMental Health

Outcome Measures

Primary Outcomes (2)

  • Quality of life

    Quality of life will be assessed using the EuroQol-5D (EQ-5D). EuroQol-5D is composed of two parts: * a five-question questionnaire with a score per question ranging from 1 (no problem) to 5 (severe problem), so that the sum ranged from 0 (no problem) to 25 (severe problem). * a visual analogue scale on participants' perceived health. This scale is numbered from 0 (i.e., the worst health the participant can imagine) to 100 (i.e., the best health the participant can imagine). This questionnaire will be completed online on the CRIUGM web platform using an electronic device.

    3 months

  • Well-being

    Well-being will be assessed using the Warwick-Edinburgh Mental Well-being Scale (WEMWBS). The WEMWBS is a validated questionnaire composed by a 14-item positively worded scale and five response categories. It covers most aspects of positive mental health (positive thoughts and feelings). This questionnaire will be completed online on the CRIUGM web platform using an electronic device.

    3 months

Secondary Outcomes (4)

  • Physical Health Status

    3 months

  • Social Isolation

    3 months

  • Prescribing context

    3 months

  • Satisfaction from the visit to the museum

    3 months

Study Arms (1)

Intervention

EXPERIMENTAL

Physicians participating in the research project will be able to prescribe a visit to the Museum to any of their patients for whom they deem this museum prescription necessary. Only patients who meet the inclusion criteria will be offered to participate in the research. If patients refuse or do not meet the inclusion criteria, they may be prescribed a museum visit but will not be offered the study. After obtaining informed consent, the patient will be asked to complete 2 sets of self-administered questionnaires: in the 2 days prior to the visit and in the 2 days following the MBAM visit.

Other: Museum visit

Interventions

The intervention is a visit of the MMFA. This visit can be done alone or accompanied. The visit of the MMFA is free for the patient.

Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age 18 and over
  • having Internet access at home with an electronic device (computer, keyboard, or smartphone)
  • having no dementia
  • speaking English or French
  • committing to visiting the museum within 3 months of the prescription.

You may not qualify if:

  • individuals participating in a clinical trial at the same time, to avoid interference with the results of the intervention being studied in this protocol
  • individuals with dementia. There are no tests for dementia. The physicians involved in the pre-recruitment process are aware of the cognitive status of their patients. Therefore, they will be able to avoid offering the study to a patient with dementia if such a diagnosis appears in the medical file.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CRIUGM

Montreal, Quebec, H3W 1W5, Canada

Location

Related Publications (1)

  • Beauchet O, Moret A, Deveault M, Thiboutot C, Parent N, Boyer H, Galery K. Physician-prescribed museum visit benefits on mental health: results of an experimental study. Front Med (Lausanne). 2025 May 14;12:1590145. doi: 10.3389/fmed.2025.1590145. eCollection 2025.

MeSH Terms

Conditions

Social IsolationArts syndromePsychological Well-Being

Condition Hierarchy (Ancestors)

Social BehaviorBehaviorPersonal Satisfaction

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Model Details: This study is experimental, prospective, open-label, non-randomized, pre-post intervention with a single group of participants who will be their own control.
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, PhD, Senior researcher, Director of laboratory

Study Record Dates

First Submitted

June 30, 2022

First Posted

July 6, 2022

Study Start

June 27, 2022

Primary Completion

July 21, 2023

Study Completion

December 22, 2023

Last Updated

February 23, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

Locations